Lazard Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-11,338	Closed	-$1.14M	–	2506
2021 Q3	$1.14M	Buy	+11,338	New	+$1.14M	﹤0.01%	1044